Optimizing Migraine Treatment Through Performance Improvement

Target Audience

This activity is intended for neurology-focused healthcare professional teams caring for patients with migraine, including neurologists, nurse practitioners, physician associates/physician assistants, and registered nurses.

Learning Objectives

Upon completion of this activity, participants should be able to: 

  • Utilizing AAN/ICSI guidelines and measures, discuss optimized treatment for patients with migraine

  • Describe the various strategies for obtaining coverage for a preventive migraine treatment medication

  • Devise a plan for improving performance on a quality measure for migraine prevention

 

Supported by an educational grant from Lilly.

 

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 ANCC
    • 1.00 ANCC Pharmacology
  • 1.00 Participation
Course opens: 
12/26/2024
Course expires: 
12/25/2025

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Shivang Joshi, MD, MPH, RPh, FAHS

 

Assistant Professor of Neurology, UMass
Director of Headache and Clinical Research
CNS Neurology
Boston, Massachusetts

 

Shivang Joshi, MD, MPH, RPh, FAHS: consultant/advisor/speaker: AbbVie, Lilly, Lundbeck, Scilex.

Amanda Macone, MD

 

Instructor of Neurology and Anesthesiology
Harvard Medical School
Comprehensive Headache Center
Beth Israel Deaconess Medical Center
One Brookline Place
Brookline, Massachusetts

 

Amanda Macone, MD: consultant/advisor/speaker: Theranica.

Natalie Sanfratello, MPH, CHCP

 

Senior Program Manager, Quality Improvement, Educational Programs, and Contracts
Barry M. Manuel Center for Continuing Education
Boston University Chobanian & Avedisian School of Medicine
Boston, Massachusetts

 

Natalie Sanfratello, MPH, CHCP, has no relevant financial relationships to disclose.

Jeremy Spiewak, PharmD, MCSR-RPh, MSC

 

Ambulatory Care Clinical Pharmacy Specialist
Adjunct Faculty Pharmacy Practice MCPHS University
Lahey IBD Center
Beth Israel Lahey Hospital
Burlington, Massachusetts

 

Jeremy Spiewak, PharmD, MCSR-RPh, MSCS, has no relevant financial relationships to disclose.

 

Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product. 

The planners and content peer reviewers from Boston University Chobanian & Avedisian School of Medicine Continuing Medical Education Office and Clinical Care Options, LLC do not have any relevant financial relationships to disclose.

Boston University Disclaimer 
THIS CONTINUING  EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.

Clinical Care Options Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Joint Accreditation

In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Physicians
Boston University Chobanian & Avedisian School of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses 
Nursing Contact Hours: 1.0, of which 1.0 is eligible for pharmacology credit.

Physician Associate Continuing Medical Education 

AAPA CME Accreditation - AAPA

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credit. Approval is valid until December 25, 2025. PAs should only claim credit commensurate with the extent of their participation.

 

Available Credit

  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 ANCC
    • 1.00 ANCC Pharmacology
  • 1.00 Participation
Please login or register to take this course.


Please click "Take Course" to be directed to the course site.